Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,424 | 157 | 94.0% |
| Education | $154.19 | 3 | 6.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| JAZZ PHARMACEUTICALS INC. | $827.77 | 49 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $421.52 | 30 | $0 (2024) |
| Harmony Biosciences LLC | $346.65 | 17 | $0 (2023) |
| Lilly USA, LLC | $164.71 | 12 | $0 (2024) |
| Novo Nordisk Inc | $98.28 | 6 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $74.41 | 4 | $0 (2023) |
| GlaxoSmithKline, LLC. | $71.33 | 5 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $70.92 | 5 | $0 (2019) |
| Bausch Health US, LLC | $59.62 | 4 | $0 (2023) |
| Aytu Bioscience, Inc | $52.76 | 4 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $235.92 | 14 | Novo Nordisk Inc ($31.91) |
| 2023 | $236.94 | 15 | JAZZ PHARMACEUTICALS INC. ($70.28) |
| 2022 | $503.70 | 26 | Harmony Biosciences LLC ($210.57) |
| 2021 | $438.53 | 31 | JAZZ PHARMACEUTICALS INC. ($170.40) |
| 2020 | $293.62 | 21 | AstraZeneca Pharmaceuticals LP ($133.28) |
| 2019 | $226.19 | 17 | JAZZ PHARMACEUTICALS INC. ($66.56) |
| 2018 | $234.40 | 18 | Jazz Pharmaceuticals Inc. ($93.74) |
| 2017 | $408.69 | 18 | Jazz Pharmaceuticals Inc. ($216.01) |
All Payment Transactions
160 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/11/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Diabetes | ||||||
| 10/25/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: Oncology | ||||||
| 10/21/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: VACCINE | ||||||
| 10/14/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Diabetes | ||||||
| 09/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: DIABETES | ||||||
| 09/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Obesity | ||||||
| 09/20/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: Endocrinology | ||||||
| 09/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/23/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: VACCINES | ||||||
| 08/16/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: VACCINES | ||||||
| 07/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/27/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 03/22/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: VACCINES | ||||||
| 02/16/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Education | In-kind items and services | $14.10 | General |
| Category: Neurology | ||||||
| 11/28/2023 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $31.07 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 11/18/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: VACCINES | ||||||
| 10/31/2023 | Harmony Biosciences LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $14.41 | General |
| Category: SLEEP MEDICINE | ||||||
| 05/16/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/09/2023 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: NEUROLOGY | ||||||
| 05/02/2023 | Harmony Biosciences LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $14.70 | General |
| Category: SLEEP MEDICINE | ||||||
| 04/11/2023 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: NEUROLOGY | ||||||
| 03/28/2023 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: NEUROLOGY | ||||||
| 03/07/2023 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Neurology | ||||||
| 02/28/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Cardio-renal | ||||||
| 02/21/2023 | Harmony Biosciences LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $14.73 | General |
| Category: SLEEP MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 261 | 415 | $109,249 | $40,296 |
| 2022 | 6 | 290 | 520 | $88,739 | $54,067 |
| 2021 | 7 | 340 | 553 | $90,675 | $56,072 |
| 2020 | 10 | 349 | 544 | $81,445 | $39,450 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 90 | 210 | $53,469 | $20,272 | 37.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 50 | 66 | $24,498 | $7,810 | 31.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 52 | 52 | $14,202 | $7,148 | 50.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 48 | 64 | $14,396 | $4,277 | 29.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 21 | 23 | $2,684 | $789.26 | 29.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 73 | 141 | $33,237 | $20,397 | 61.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 80 | 195 | $35,349 | $20,148 | 57.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 42 | 42 | $7,092 | $5,961 | 84.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 48 | 79 | $5,944 | $3,757 | 63.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 35 | 49 | $6,375 | $3,511 | 55.1% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 12 | 14 | $742.00 | $293.02 | 39.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 88 | 156 | $35,100 | $21,700 | 61.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 95 | 198 | $34,650 | $19,302 | 55.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 46 | 46 | $6,900 | $6,656 | 96.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 45 | 65 | $8,125 | $5,145 | 63.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 39 | 57 | $4,275 | $2,560 | 59.9% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 13 | 17 | $1,275 | $455.60 | 35.7% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2021 | 14 | 14 | $350.00 | $252.70 | 72.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 82 | 140 | $31,500 | $14,446 | 45.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 79 | 175 | $30,625 | $14,085 | 46.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 40 | 40 | $6,100 | $5,051 | 82.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 36 | 52 | $6,500 | $3,049 | 46.9% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 31 | 40 | $3,000 | $1,479 | 49.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 18 | 26 | $910.00 | $476.73 | 52.4% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 14 | 20 | $1,060 | $391.60 | 36.9% |
About Dr. Daniel Jass, MD
Dr. Daniel Jass, MD is a Family Medicine healthcare provider based in Ewing, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184715542.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Jass, MD has received a total of $2,578 in payments from pharmaceutical and medical device companies, with $235.92 received in 2024. These payments were reported across 160 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($2,424).
As a Medicare-enrolled provider, Jass has provided services to 1,240 Medicare beneficiaries, totaling 2,032 services with total Medicare billing of $189,885. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Ewing, NJ
- Active Since 09/28/2006
- Last Updated 05/30/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1184715542
Products in Payments
- FARXIGA (Drug) $409.09
- XYWAV (Drug) $383.56
- Xyrem (Drug) $309.75
- Wakix (Drug) $302.81
- XYREM (Drug) $106.89
- TRULICITY (Drug) $79.67
- Kerendia (Drug) $74.41
- NUEDEXTA (Drug) $70.92
- SHINGRIX (Biological) $59.00
- Natesto (Drug) $52.76
- Rybelsus (Drug) $50.67
- APLENZIN (Drug) $50.21
- LUMRYZ (Drug) $48.51
- WAKIX (Drug) $43.84
- BASAGLAR (Drug) $39.76
- WELLBUTRIN (Drug) $33.46
- Sunosi (Drug) $29.50
- EMGALITY (Drug) $28.22
- XTAMPZA (Drug) $27.96
- SUNOSI (Drug) $27.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Ewing
Dr. Kashif Anwar, M.d, M.D
Family Medicine — Payments: $5,927
Joshua Yeary, Do, DO
Family Medicine — Payments: $3,190
Dr. Stephen Licetti, D.o, D.O
Family Medicine — Payments: $1,245
Dr. Tara Vanhise, D.o, D.O
Family Medicine — Payments: $490.90
Meriam Khan, Do, DO
Family Medicine — Payments: $182.57